We are live on ! Find out more
MG

Meditor Group Portfolio holdings

AUM $48.1M
1-Year Est. Return 38.67%
This Fund
S&P 500
This Quarter Est. Return
-4.47%
1 Year Est. Return
+38.67%
3 Year Est. Return
+41.15%
5 Year Est. Return
+72.2%
10 Year Est. Return
+1,065.64%
AUM
$497M
AUM Growth
-$36.2M
Cap. Flow
-$1.96M
Cap. Flow %
-0.39%
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
EXEL icon
Exelixis
EXEL
+$1.96M

Sector Composition

Rank Sector Weight
1 Healthcare 93.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EXEL icon
1
Exelixis
EXEL
$13.9B
$321M 64.48%
15,001,073
-93,422
-0.6% -$1.96M
ESPR
2
DELISTED
Esperion Therapeutics
ESPR
$125M 25.08%
2,679,835
– –
ALKS icon
3
Alkermes
ALKS
$8.82B
$20.1M 4.05%
892,400
– –
INDA icon
4
iShares MSCI India ETF
INDA
$6.71B
$11.3M 2.27%
320,000
– –
EPI icon
5
WisdomTree India Earnings Fund ETF
EPI
$2.02B
$10.4M 2.1%
400,000
– –
SDS icon
6
ProShares UltraShort S&P500
SDS
$406M
$3.53M 0.71%
4,600
– –
SPXU icon
7
ProShares UltraPro Short S&P 500
SPXU
$436M
$2.92M 0.59%
1,050
– –
SQQQ icon
8
ProShares UltraPro Short QQQ
SQQQ
$2.21B
$2.5M 0.5%
114
– –
CLDX icon
9
Celldex Therapeutics
CLDX
$2.77B
$1.13M 0.23%
420,846
– –

Similar funds

BHCM
Boulder Hill Capital Management New York $47.9M AUM
VMV
Venrock Management VI Palo Alto, California $47.6M AUM 45.26% 1-Year Est. Return
BHH
Baker Hughes Holdings Houston, Texas $47.6M AUM 26.35% 1-Year Est. Return
LAMC
Lubert-Adler Management Company Philadelphia, Pennsylvania $49.3M AUM 17.46% 1-Year Est. Return
MAM
Miria Asset Management St. Julians, Malta $49.9M AUM 21.84% 1-Year Est. Return
BCM
BlueMar Capital Management Miami, Florida $49.9M AUM 28.76% 1-Year Est. Return
LOF
Lightspeed Opportunity Fund Menlo Park, California $50.1M AUM 53.1% 1-Year Est. Return
CLCM
Center Lake Capital Management West Palm Beach, Florida $45.8M AUM 58.23% 1-Year Est. Return

Meditor Group's Q2 2019 Portfolio in Review

As of Q2 2019, Meditor Group held 9 positions worth $497M, down 6.8% from $533M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2019: portfolio turnover was 0%. Meditor Group opened no new positions and made no exits, leaving the 9-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, down from 94% a quarter earlier.

  • Meditor Group's biggest Q2 2019 reduction was Exelixis, cutting an estimated $1.96M.
  • Meditor Group's ten largest holdings make up 100% of its $497M portfolio in Q2 2019.
  • Meditor Group opened 0 new positions and closed 0 in Q2 2019.
  • Meditor Group's portfolio value fell 6.8% quarter-over-quarter to $497M.

Based on Meditor Group's 13F filing for Q2 2019, filed 24 Jul 2019.